Literature DB >> 3769381

Reduction of liver plasma flow by caffeine and theophylline.

J Onrot, O Shaheen, I Biaggioni, M R Goldberg, J Feely, G R Wilkinson, A S Hollister, D Robertson.   

Abstract

Caffeine and theophylline block the vasodilating effects of adenosine and may act to enhance sympathoadrenal discharge and activate the renin-angiotensin system. To determine if these methylxanthines might thereby have effects on regional blood flow, we studied the influence of caffeine and theophylline on apparent liver plasma flow (LPF) in normal subjects as assessed by indocyanine green clearance. Oral caffeine, 250 mg, reduced LPF by 19% from 630 +/- 150 to 510 +/- 120 ml/min (P less than 0.001). Intravenous theophylline (4.3 mg/kg) reduced LPF by 15% from 550 +/- 50 to 470 +/- 90 ml/min (P less than 0.05). These methylxanthine-induced falls in LPF may alter the disposition of concomitantly administered drugs. Because of their widespread use in Western society, caffeine and theophylline may be major determinants of liver blood flow in the general population. They may therefore prolong the t1/2 and increase steady-state levels of hepatically eliminated drugs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3769381     DOI: 10.1038/clpt.1986.215

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  8 in total

1.  Pharmacokinetic and pharmacodynamic assessment of a five-probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1.

Authors:  G E Blakey; J A Lockton; J Perrett; P Norwood; M Russell; Z Aherne; J Plume
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

2.  Quantitative assessment of hepatic blood flow using intravenous indocyanine green.

Authors:  Joseph D Ma; Anne N Nafziger; William Mylott; David B Haughey; Mario L Rocci; Joseph S Bertino
Journal:  Eur J Clin Pharmacol       Date:  2008-07-02       Impact factor: 2.953

3.  Increased theophylline clearance in asthmatic patients due to terbutaline.

Authors:  M Garty; L Paul-Keslin; D N Ilfeld; A Mazar; S Spitzer; J B Rosenfeld
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 4.  The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion.

Authors:  I Walter-Sack
Journal:  Klin Wochenschr       Date:  1987-11-02

Review 5.  A benefit-risk assessment of caffeine as an analgesic adjuvant.

Authors:  W Y Zhang
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium.

Authors:  Luigi Alberto Pini; Enrico Del Bene; Giorgio Zanchin; Paola Sarchielli; Girolamo Di Trapani; Maria Pia Prudenzano; Giovanni LaPegna; Lidia Savi; Giorgio Di Loreto; Paolo Dionisio; Franco Granella
Journal:  J Headache Pain       Date:  2008-09-25       Impact factor: 7.277

7.  Correlation of caffeine elimination and Child's classification in liver cirrhosis.

Authors:  A Holstege; M Staiger; K Haag; W Gerok
Journal:  Klin Wochenschr       Date:  1989-01-04

8.  Cardiovascular effects of eating, atenolol and their interaction: beta1-adrenergic modulation does not play a predominant role in the genesis of postprandial effects.

Authors:  C De Mey; D Enterling; I Meineke
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.